Helsinn to co-support a satellite symposium on current and emerging treatments of Acute Myeloid Leukemia (AML) at 24th European Hematology Association (EHA) Congress

12 June 2019

Helsinn Group supports two events with the International Society for Cutaneous Lymphomas (ISCL) at the 24th World Congress of Dermatology

7 June 2019

Helsinn Group Announces Upcoming Presentation of Phase 3b data of NEPA (fosnetupitant / palonosetron) IV at ASCO 2019 – The NEPA IV formulation was evaluated for safety in the AC setting.

4 June 2019

Conquer Cancer Foundation/Anna Braglia Endowed Young Investigator Award (YIA) in Cancer Supportive Care, supported by Helsinn, awarded to Dr. Allison Barz Leahy, MD, University of Pennsylvania

4 June 2019

ARDIAN INVESTE IN SINTETICA, STORICA AZIENDA FARMACEUTICA SVIZZERA, PER SUPPORTARE LA STRATEGIA DI INTERNAZIONALIZZAZIONE

24 May 2019

39a Assemblea generale ordinaria di Farma Industria Ticino

23 May 2019

Helsinn and Mundipharma China Pharmaceutical together announce the launch of ALOXI® IV in China and a Co-Detailing collaboration in Shanghai

9 May 2019

Helsinn nominated as a Swiss Biotech Success Story 2019/2020 by the Swiss Biotech Association

8 May 2019

On 15 May 2019 Farma Industria Ticino will be at the University Hospital Center (CHUV) in Lausanne looking for talents

29 April 2019

Helsinn Supports Local Art Exhibition, ‘Lugano: Reflections of Light’ by Helidon Xhixha, curated by Eike D. Schmidt

19 April 2019